Skip to content

Effects of a program of strengthening exercise in subjects with Parkinson's disease

Strengthening exercise in individuals with parkinson´s disease: A randomised trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-4g7q2c
Enrollment
Unknown
Registered
2012-07-16
Start date
2011-11-15
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson´s disease

Interventions

The participants will receive training for 10 weeks at a frequency of three times per week and duration of 40 minutes each session. Sixteen will be recruited for each group. Physical therapists will b
dorsoflexores and the ankle plantar flexors. Each session will include: (1) 10 minute warm up (calisthenics, stretching and light exercises range of motion), (2): 20 minutes of muscle strength trainin
other
E02.779.483.875
I02.233.543

Sponsors

Universidade Federal de Minas Gerais-UFMG
Lead Sponsor
Universidade Federal de Minas Gerais-UFMG
Collaborator

Eligibility

Age
50 Years to 90 Years

Inclusion criteria

Inclusion criteria: Are older than 50 years of age; Have a diagnosis of PD; In stages I to IV of the Disability Stages of Hoehn & Yahr; Be stable use of anti-parkinsonian; Have good comprehension (assessed using the Mini Mental State Examination score); Signing the informed consent

Exclusion criteria

Exclusion criteria: Adverse medical conditions that may prevent participation in the proposed protocols as decompensated hypertension, neurological diseases or other rheumatic diseases of any kind; Individuals who are in physical therapy for at least 02 months before the randomisation procedure.

Design outcomes

Primary

MeasureTime frame
Expected Outcome: Increased muscle strength. Measures of muscle strength will be obtained with a manual dynamometer. Will be assessed maximal isometric force, supported by five seconds, the following muscle groups: the dorsal and plantar flexors and extensors and flexors of the knee and hip. This instrument provides measurements in kilograms-force (kgf), which will be converted to Newton-meters (Nm) with correction of gravity. The proposed measure will be obtained before, immediately after intervention and one month after the intervention

Secondary

MeasureTime frame
Expected outcome: improved balance and gait parameters (walking speed, cadence, step length). The balance will be assessed using the Berg Bal ¬ ance Scale (BBS). It comprises 14 items that measure the static and dynamic balance in different situations. The running is evaluated by means of equipment GAITRite ® system. The GAITRite ® system consists of a mat with electronic sensors positioned to capture spatiotemporal measures of gait. All the proposed measures shall be obtained before, immediately after the intervention and one month after the intervention.;Expected outcome: improvement of clinical and functional performance and quality of life of individuals with PD. The UPDRS is a scale clinical evaluation of patients with PD and has four domains (mental activity, behavior and mood, activities of daily living, motor exploration and complications of drug treatment) which are evaluated in a semi-quantitative. All the proposed measures shall be obtained before, immediately after the intervention and one month after the intervention. The PDQ-39 indicates the overall impact of PD on the well-being and health of the individual as well as being sensitive to the effects of different treatments.

Countries

Brazil

Contacts

Public ContactLidiane Lima

Universidade Federal de Minas Gerais-UFMG

lidianelima848@hotmail.com(31) 9143-5050

Outcome results

None listed

Source: REBEC (via WHO ICTRP)